Indian generics muscle into global weight-loss gold rush as Novo Nordisk's patent crumbles

In the high-stakes world of patents, a "thumping victory" in the Delhi High Court has fundamentally rewritten the playbook for India’s pharmaceutical generics giants. Is the next great weight-loss drug battle...

Already a subscriber? Click here to view full article